BUTTARI, FABIO
 Distribuzione geografica
Continente #
NA - Nord America 157
EU - Europa 92
AS - Asia 56
SA - Sud America 1
Totale 306
Nazione #
US - Stati Uniti d'America 156
DE - Germania 64
SG - Singapore 52
IT - Italia 27
BD - Bangladesh 3
BR - Brasile 1
IL - Israele 1
LT - Lituania 1
MX - Messico 1
Totale 306
Città #
Frankfurt am Main 63
West Jordan 62
Boardman 35
Singapore 31
Rome 6
Buffalo 5
Naples 5
Bologna 4
Ashburn 3
Charlotte 3
Zona Industriale 2
Arosio 1
Council Bluffs 1
Ettlingen 1
Kiryat Ono 1
Los Angeles 1
Mexico City 1
São Paulo 1
Totale 226
Nome #
Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients 17
Modeling Resilience to Damage in Multiple Sclerosis: Plasticity Meets Connectivity 16
Distinct intrathecal inflammatory signatures following relapse and anti-COVID-19 mRNA vaccination in multiple sclerosis 13
Interleukin 6 SNP rs1818879 Regulates Radiological and Inflammatory Activity in Multiple Sclerosis 13
BACE1 influences clinical manifestations and central inflammation in relapsing remitting multiple sclerosis 12
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis 10
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis 10
Interleukin-1β Alters Hebbian Synaptic Plasticity in Multiple Sclerosis 10
Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple Sclerosis 9
Interaction between miR-142-3p and BDNF Val/Met Polymorphism Regulates Multiple Sclerosis Severity. 9
Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis. 9
Transient receptor potential vanilloid 1 modulates central inflammation in multiple sclerosis 9
Exploiting the multifaceted effects of cannabinoids on mood to boost their therapeutic use against anxiety and depression 9
A Single Nucleotide ADA Genetic Variant Is Associated to Central Inflammation and Clinical Presentation in MS: Implications for Cladribine Treatment 9
Cerebrospinal fluid, brain, and spinal cord levels of L-aspartate signal excitatory neurotransmission abnormalities in multiple sclerosis patients and experimental autoimmune encephalomyelitis mouse model 9
Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity 9
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis 9
Cerebrospinal fluid levels of L-glutamate signal central inflammatory neurodegeneration in multiple sclerosis 8
IL-6 in the Cerebrospinal Fluid Signals Disease Activity in Multiple Sclerosis 8
Osteopontin Is Associated with Multiple Sclerosis Relapses 8
Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis 8
Synaptic plasticity shapes brain connectivity: Implications for network topology 8
Genetic regulation of IL-8 influences disease presentation of multiple sclerosis 8
Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis 8
Preventive exercise and physical rehabilitation promote long-term potentiation-like plasticity expression in patients with multiple sclerosis 7
Practice-dependent motor cortex plasticity is reduced in non-disabled multiple sclerosis patients 7
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course 7
The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis 7
Remodeling functional connectivity in multiple sclerosis: A challenging therapeutic approach 7
Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple Sclerosis 7
The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple Sclerosis 7
Obesity worsens central inflammation and disability in multiple sclerosis 7
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis 6
Inflammation and Corticospinal Functioning in Multiple Sclerosis: A TMS Perspective 6
Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients 6
Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis 5
Mood disturbances in newly diagnosed Parkinson's Disease patients reflect intrathecal inflammation. 5
Exploring the role of microglia in mood disorders associated with experimental multiple sclerosis 5
Inflammatory signature in amyotrophic lateral sclerosis predicting disease progression 4
Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis 4
Tumor Necrosis Factor and Interleukin-1β Modulate Synaptic Plasticity during Neuroinflammation 4
Peripheral T cells from multiple sclerosis patients trigger synaptotoxic alterations in central neurons 4
Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis 4
Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions 3
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis 3
miR-142-3p Is a Key Regulator of IL-1??-Dependent Synaptopathy in Neuroinflammation 3
Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis 3
Re-Examining the Role of TNF in MS Pathogenesis and Therapy 3
An IL-5 Single-Nucleotide Polymorphism Influences Neuroinflammation and Prospective Disease Activity in Multiple Sclerosis 2
'Prototypical' proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targeting 2
Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination 2
Totale 368
Categoria #
all - tutte 4.366
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.366


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024198 0 0 0 0 0 0 45 0 0 125 15 13
2024/2025170 35 45 7 49 34 0 0 0 0 0 0 0
Totale 368